Mirikizumab showed superior maintenance efficacy over most treatments for ulcerative colitis (UC), according to a network ...

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...

Alongside margin recovery, Biocon Biologics has also gained market share, with oncology remaining a key focus area.

All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the ...

We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...

Q4 2024 Earnings Call Transcript February 4, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $5.31, expectations ...

In immunology, J&J looks well positioned to mitigate the patent loss for an older immunology drug Stelara with recently ... generic competition for small-molecule drugs and biologics.

So it really is a very exciting moment for a molecule like this ... So if you look at a Humira, Stelara, Cosentyx, they're all starting single pathways. The science of TL1A is it's an amplifier ...

"Under the IRA, which discourages the research and development of additional indications for small molecule medicines ... and Johnson & Johnson's Stelara (ustekinumab). Calling the policy a ...